Bio-Rad Laboratories, Inc. – NYSE:BIO
Bio-Rad Laboratories stock price today
$286.14
-44.73
-13.52%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 2 hours
Bio-Rad Laboratories stock price monthly change
+8.79%
month
Bio-Rad Laboratories stock price quarterly change
+8.79%
quarter
Bio-Rad Laboratories stock price yearly change
+2.71%
year
Bio-Rad Laboratories key metrics
Market Cap | 9.12B |
Enterprise value | 14.77B |
P/E | -3.85 |
EV/Sales | 5.27 |
EV/EBITDA | -7.54 |
Price/Sales | 4.99 |
Price/Book | 1.45 |
PEG ratio | 0.02 |
EPS | -10.33 |
Revenue | 2.60B |
EBITDA | 541.26M |
Income | -322.37M |
Revenue Q/Q | -9.75% |
Revenue Y/Y | -6.25% |
Profit margin | -129.66% |
Oper. margin | 16.95% |
Gross margin | 56.04% |
EBIT margin | 16.95% |
EBITDA margin | 20.78% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBio-Rad Laboratories stock price history
Bio-Rad Laboratories stock forecast
Bio-Rad Laboratories financial statements
| Jun 2023 | 681.11M | -1.16B | -170.64% |
|---|---|---|---|
| Sep 2023 | 632.12M | 106.25M | 16.81% |
| Dec 2023 | 681.18M | 349.70M | 51.34% |
| Mar 2024 | 610.82M | 383.91M | 62.85% |
| Sep 2025 | 699.29M | 83.33M | 11.92% |
|---|---|---|---|
| Oct 2025 | 695.71M | 80.87M | 11.62% |
| Dec 2025 | 766.13M | 106.74M | 13.93% |
| Mar 2026 | 683.21M | 85.72M | 12.55% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 11978229000 | 3.53B | 29.48% |
|---|---|---|---|
| Sep 2023 | 11895943000 | 3.47B | 29.25% |
| Dec 2023 | 12299070000 | 3.55B | 28.93% |
| Mar 2024 | 12609893000 | 3.55B | 28.22% |
| Jun 2023 | 98.06M | 27.98M | -202.73M |
|---|---|---|---|
| Sep 2023 | 97.71M | -9.5M | -26.59M |
| Dec 2023 | 81.04M | 72.19M | -200.62M |
| Mar 2024 | 69.17M | -43.09M | 638K |
Bio-Rad Laboratories alternative data
| Sep 2023 | 8,200 |
|---|---|
| Oct 2023 | 8,200 |
| Nov 2023 | 8,000 |
| Dec 2023 | 8,000 |
| Jan 2024 | 8,000 |
| Feb 2024 | 8,000 |
| Apr 2024 | 8,030 |
| May 2024 | 8,030 |
| Jun 2024 | 8,000 |
| Jul 2024 | 8,000 |
Bio-Rad Laboratories other data
58.62%
-4.41%
of BIO is owned by hedge funds
438
-44
17.46M
-1.40M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2023 | 0 | 1746 |
| Jun 2023 | 0 | 698 |
| Aug 2023 | 0 | 2650 |
| Nov 2023 | 0 | 642 |
| Dec 2023 | 0 | 1200 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | WRIGHT DARA officer: EVP, Pre.. | Bio-Rad A Common Stock | 502 | N/A | N/A | ||
Option | WRIGHT DARA officer: EVP, Pre.. | Bio-Rad A Common Stock | 502 | N/A | N/A | ||
Option | WRIGHT DARA officer: EVP, Pre.. | Restricted Stock Units | 502 | N/A | N/A | ||
Option | WRIGHT DARA officer: EVP, Pre.. | Restricted Stock Units | 502 | N/A | N/A | ||
Sale | WRIGHT DARA officer: EVP, Pre.. | Bio-Rad A Common Stock | 1,200 | $299.16 | $358,992 | ||
Sale | WRIGHT DARA officer: EVP, Pre.. | Bio-Rad A Common Stock | 1,200 | $299.16 | $358,992 | ||
Sale | CROWLEY MICHAEL officer: EVP, GBL Commercial Op.. | Bio-Rad A Common Stock | 642 | $305.1 | $195,874 | ||
Option | SCHWARTZ NORMAN D director, 10 perc.. | Bio-Rad B Common Stock | 35,000 | $119.8 | $4,193,000 | ||
Option | SCHWARTZ NORMAN D director, 10 perc.. | Bio-Rad B Common Stock | 35,000 | $119.8 | $4,193,000 | ||
Option | SCHWARTZ NORMAN D director, 10 perc.. | Bio-Rad B Common Stock | 15,000 | $159.32 | $2,389,800 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 15 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 26 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Bio-Rad: A Cash Flow Returns On Investments Analysis
Bio-Rad And Its Real Value
Bio-Rad: Aggressively Buying In FY 2023
Qiagen Offers Growth And Margin Leverage Beyond The Pandemic Deceleration
Charles River Laboratories International: A Great Business At A Decent Price
Bruker Corp.: My Top Ranked Holding In Laboratory Analytical Instruments
Bio-Rad: How Efficient Is Its Capital Management? A Deep Look, With Technicals
Diagnosing PerkinElmer
Guardant Health: Leaping Growth With Epic
-
What's the price of Bio-Rad Laboratories stock today?
One share of Bio-Rad Laboratories stock can currently be purchased for approximately $286.14.
-
When is Bio-Rad Laboratories's next earnings date?
Unfortunately, Bio-Rad Laboratories's (BIO) next earnings date is currently unknown.
-
Does Bio-Rad Laboratories pay dividends?
No, Bio-Rad Laboratories does not pay dividends.
-
How much money does Bio-Rad Laboratories make?
Bio-Rad Laboratories has a market capitalization of 9.12B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 4.67% to 2.67B US dollars.
-
What is Bio-Rad Laboratories's stock symbol?
Bio-Rad Laboratories, Inc. is traded on the NYSE under the ticker symbol "BIO".
-
What is Bio-Rad Laboratories's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Bio-Rad Laboratories?
Shares of Bio-Rad Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Bio-Rad Laboratories's key executives?
Bio-Rad Laboratories's management team includes the following people:
- Mr. Norman D. Schwartz Chairman, Chief Executive Officer & Pres(age: 75, pay: $3,010,000)
- Dr. Andrew J. Last Executive Vice President & Chief Operating Officer(age: 65, pay: $1,500,000)
- Ms. Dara Grantham Wright Executive Vice President & Pres of Clinical Diagnostics Group(age: 49, pay: $1,390,000)
- Mr. Ilan Daskal Executive Vice President & Chief Financial Officer(age: 59, pay: $1,160,000)
-
How many employees does Bio-Rad Laboratories have?
As Jul 2024, Bio-Rad Laboratories employs 8,000 workers, which is 0% less then previous quarter.
-
When Bio-Rad Laboratories went public?
Bio-Rad Laboratories, Inc. is publicly traded company for more then 45 years since IPO on 27 Feb 1980.
-
What is Bio-Rad Laboratories's official website?
The official website for Bio-Rad Laboratories is bio-rad.com.
-
Where are Bio-Rad Laboratories's headquarters?
Bio-Rad Laboratories is headquartered at 1000 Alfred Nobel Drive, Hercules, CA.
-
How can i contact Bio-Rad Laboratories?
Bio-Rad Laboratories's mailing address is 1000 Alfred Nobel Drive, Hercules, CA and company can be reached via phone at +51 07247000.
Bio-Rad Laboratories company profile:
Bio-Rad Laboratories, Inc.
bio-rad.comExchange:
NYSE
Full time employees:
7,700
Industry:
Medical - Devices
Sector:
Healthcare
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
1000 Alfred Nobel Drive
Hercules, CA 94547
Hercules, CA 94547
CIK: 0000012208
ISIN: US0905722072
CUSIP: 090572207
